PH12019501950A1 - Intradialytic use of sodium nitrite - Google Patents
Intradialytic use of sodium nitriteInfo
- Publication number
- PH12019501950A1 PH12019501950A1 PH12019501950A PH12019501950A PH12019501950A1 PH 12019501950 A1 PH12019501950 A1 PH 12019501950A1 PH 12019501950 A PH12019501950 A PH 12019501950A PH 12019501950 A PH12019501950 A PH 12019501950A PH 12019501950 A1 PH12019501950 A1 PH 12019501950A1
- Authority
- PH
- Philippines
- Prior art keywords
- sodium nitrite
- intradialytic
- methods
- nitrite
- subject undergoing
- Prior art date
Links
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 title abstract 4
- 235000010288 sodium nitrite Nutrition 0.000 title abstract 2
- 238000001631 haemodialysis Methods 0.000 abstract 2
- 230000000322 hemodialysis Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- External Artificial Organs (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762468857P | 2017-03-08 | 2017-03-08 | |
| PCT/US2018/021053 WO2018165098A1 (en) | 2017-03-08 | 2018-03-06 | Intradialytic use of sodium nitrite |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12019501950A1 true PH12019501950A1 (en) | 2020-06-15 |
Family
ID=63445965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12019501950A PH12019501950A1 (en) | 2017-03-08 | 2019-08-23 | Intradialytic use of sodium nitrite |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US10328099B2 (https=) |
| EP (2) | EP4406595A3 (https=) |
| JP (3) | JP7314050B2 (https=) |
| KR (4) | KR20250017763A (https=) |
| AR (1) | AR111166A1 (https=) |
| AU (2) | AU2018231016B2 (https=) |
| BR (1) | BR112019018861A2 (https=) |
| CA (1) | CA3055105A1 (https=) |
| ES (1) | ES2986444T3 (https=) |
| IL (4) | IL312092B2 (https=) |
| NZ (4) | NZ797744A (https=) |
| PH (1) | PH12019501950A1 (https=) |
| TW (3) | TWI835595B (https=) |
| WO (1) | WO2018165098A1 (https=) |
| ZA (3) | ZA201905679B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019018861A2 (pt) * | 2017-03-08 | 2023-10-10 | Hope Medical Entpr Inc Dba Hope Pharmaceuticals | Uso de nitrito de sódio, método para manter os níveis fisiológicos de nitrito, prevenir enfarte do miocárdio, prevenir morte súbita cardíaca, prevenir acidente vascular cerebral, doenças cardiovasculares, pressão alta, solução aquosa |
| IL268883B (en) | 2017-03-08 | 2022-09-01 | Hope Medical Entpr Inc Dba Hope Pharmaceuticals | Intradialytic use of sodium thiosulfate |
| EP4005611B1 (en) * | 2019-07-22 | 2025-11-26 | School Juridical Person The Kitasato Institute | Dialysis device |
| US20230149732A1 (en) * | 2021-11-17 | 2023-05-18 | Wake Forest University Health Sciences | Combined nitrite and light treatment to prevent device thrombosis |
| CN120456938A (zh) | 2022-12-16 | 2025-08-08 | 费森尤斯医疗保健控股公司 | 用于在透析中使用一氧化氮的系统和方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0218900B1 (en) | 1985-09-10 | 1992-01-22 | Research Corporation Technologies, Inc. | Osmotic agents for peritoneal dialysis |
| US6380163B1 (en) | 1992-12-22 | 2002-04-30 | Baxter International Inc. | Peritoneal dialysis solutions with polypeptides |
| FI98538C (fi) | 1993-10-20 | 1997-07-10 | Enso Gutzeit Oy | Menetelmä natriumhydroksidin valmistamiseksi valkolipeästä |
| US6306836B1 (en) | 1994-01-21 | 2001-10-23 | Baxter International Inc. | Peritoneal dialysis solutions containing maltodextrins and amino acids |
| US6436969B1 (en) | 1995-09-12 | 2002-08-20 | Kansas University Medical Center Research Institute Inc. | Dialysis solutions and methods |
| JP4882054B2 (ja) | 2000-09-13 | 2012-02-22 | 独立行政法人科学技術振興機構 | 腹膜透析液およびその調製法 |
| JP5564158B2 (ja) * | 2003-07-09 | 2014-07-30 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 亜硝酸塩によって特定の心臓血管状態を処置する方法 |
| US7362274B1 (en) * | 2004-07-09 | 2008-04-22 | Huan-Cheng Lien | Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna |
| US20070154570A1 (en) * | 2004-09-29 | 2007-07-05 | Miller Christopher C | Use of nitric oxide in the treatment and disinfection of biofilms |
| US7547637B2 (en) * | 2005-06-21 | 2009-06-16 | Intel Corporation | Methods for patterning a semiconductor film |
| US20090304600A1 (en) | 2008-06-09 | 2009-12-10 | Anupkumar Shetty | Intradialytic administration of sodium thiosulfate |
| US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
| AU2010270605B2 (en) | 2009-07-08 | 2014-07-31 | Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals | Sodium thiosulfate-containing pharmaceutical compositions |
| CA2844759A1 (en) * | 2011-08-11 | 2013-02-14 | Nathan S. Bryan | Method of measuring and monitoring in vivo nitrite levels |
| WO2013112582A1 (en) | 2012-01-23 | 2013-08-01 | Santalis Pharmaceuticals Inc. | Sandalwood oil and its uses related to clostridium infections |
| JP5486069B1 (ja) | 2012-11-05 | 2014-05-07 | 旭 酒井 | 透析装置 |
| US20140350097A1 (en) | 2013-05-23 | 2014-11-27 | Medinox,Inc. | Treatment of hypotension associated with hemodialysis |
| JP6183832B2 (ja) * | 2013-06-19 | 2017-08-23 | 扶桑薬品工業株式会社 | 酸化ストレス抑制型透析用剤およびその調製方法 |
| BR112019018861A2 (pt) * | 2017-03-08 | 2023-10-10 | Hope Medical Entpr Inc Dba Hope Pharmaceuticals | Uso de nitrito de sódio, método para manter os níveis fisiológicos de nitrito, prevenir enfarte do miocárdio, prevenir morte súbita cardíaca, prevenir acidente vascular cerebral, doenças cardiovasculares, pressão alta, solução aquosa |
-
2018
- 2018-03-06 BR BR112019018861A patent/BR112019018861A2/pt unknown
- 2018-03-06 IL IL312092A patent/IL312092B2/en unknown
- 2018-03-06 KR KR1020257002477A patent/KR20250017763A/ko active Pending
- 2018-03-06 EP EP24182318.6A patent/EP4406595A3/en active Pending
- 2018-03-06 ES ES18763384T patent/ES2986444T3/es active Active
- 2018-03-06 KR KR1020247008154A patent/KR102706379B1/ko active Active
- 2018-03-06 AU AU2018231016A patent/AU2018231016B2/en active Active
- 2018-03-06 JP JP2019548431A patent/JP7314050B2/ja active Active
- 2018-03-06 EP EP18763384.7A patent/EP3592342B1/en active Active
- 2018-03-06 KR KR1020247030224A patent/KR102760913B1/ko active Active
- 2018-03-06 NZ NZ797744A patent/NZ797744A/en unknown
- 2018-03-06 NZ NZ797740A patent/NZ797740A/en unknown
- 2018-03-06 IL IL301302A patent/IL301302B2/en unknown
- 2018-03-06 NZ NZ789172A patent/NZ789172A/en unknown
- 2018-03-06 CA CA3055105A patent/CA3055105A1/en active Pending
- 2018-03-06 NZ NZ756701A patent/NZ756701A/en unknown
- 2018-03-06 WO PCT/US2018/021053 patent/WO2018165098A1/en not_active Ceased
- 2018-03-06 KR KR1020197029157A patent/KR102647803B1/ko active Active
- 2018-03-07 TW TW112109906A patent/TWI835595B/zh active
- 2018-03-07 US US15/914,353 patent/US10328099B2/en active Active
- 2018-03-07 TW TW107107745A patent/TWI798203B/zh active
- 2018-03-07 TW TW113105276A patent/TWI888012B/zh active
- 2018-03-07 AR ARP180100529A patent/AR111166A1/es not_active Application Discontinuation
-
2019
- 2019-05-03 US US16/403,428 patent/US10898512B2/en active Active
- 2019-08-23 PH PH12019501950A patent/PH12019501950A1/en unknown
- 2019-08-23 IL IL268882A patent/IL268882B/en unknown
- 2019-08-28 ZA ZA2019/05679A patent/ZA201905679B/en unknown
-
2020
- 2020-11-23 US US17/102,411 patent/US11564938B2/en active Active
-
2021
- 2021-07-07 IL IL284684A patent/IL284684B2/en unknown
-
2022
- 2022-07-29 ZA ZA2022/08504A patent/ZA202208504B/en unknown
-
2023
- 2023-01-03 US US18/092,569 patent/US12011456B2/en active Active
- 2023-07-12 JP JP2023114331A patent/JP7551858B2/ja active Active
- 2023-07-25 ZA ZA2023/07367A patent/ZA202307367B/en unknown
-
2024
- 2024-05-08 US US18/658,338 patent/US20240285677A1/en active Pending
- 2024-05-28 AU AU2024203535A patent/AU2024203535B2/en active Active
- 2024-09-04 JP JP2024152352A patent/JP7765687B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202307367B (en) | Intradialytic use of sodium nitrite | |
| ZA202209104B (en) | Intradialytic use of sodium thiosulfate | |
| MX2015017201A (es) | Derivados de pirazolopiridina para uso en el tratamiento del cancer de vejiga. | |
| MY186977A (en) | Tetrasubstituted alkene compounds and their use | |
| MY174727A (en) | Stable, protracted glp-1/glucagon receptor co-agonists for medical use | |
| PH12016502355A1 (en) | Pharmaceutical composition | |
| PH12021551235A1 (en) | Elacestrant in combination with abemaciclib in women with breast cancer | |
| MX2017000366A (es) | Terapia de combinacion para el cancer. | |
| TW201613578A (en) | Pharmaceutical combinations | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| MX376029B (es) | Compuestos de isoindol. | |
| MX2019000677A (es) | Células miméticas de células b. | |
| MX2015014939A (es) | Nuevo uso de clorhidrato de landiolol en el tratamiento a largo plazo de taquiarritmias e hipertension. | |
| PE20170469A1 (es) | Metodos para mejorar el rendimiento miocardico en pacientes con cirugia de fontano que utilizan composiciones de udenafilo | |
| PH12014500381A1 (en) | Therapeutic methods | |
| MX2017015664A (es) | Administracion intravenosa de citrulina durante cirugia. | |
| MX2023001425A (es) | Inhibidores de cinasa de insercion proviral en linfomas murinos (pim) para el tratamiento de neoplasias mieloproliferativas y fibrosis asociadas con cancer. | |
| MY195767A (en) | Treatment of Androgen Deprivation Therapy Associated Symptoms | |
| EA201590760A1 (ru) | Применение бремеланотида в терапии женской сексуальной дисфункции | |
| MX2020006451A (es) | Tratamiento de la fibrosis con inositol. | |
| UA69624U (uk) | Спосіб профілактики загострення хронічного бронхіту у хворих зі сполученим перебігом з пептичною виразкою дванадцятипалої кишки | |
| UA100902U (uk) | Спосіб лікування мікрогландулярної гіперплазії шийки матки у жінок із порушеннями вегетативного гомеостазу | |
| IN2014DE00818A (https=) | ||
| UA69733U (ru) | Способ диагностики диастолической дисфункции левого желудочка у больных с неосложненной гипертонической болезнью | |
| UA83680U (ru) | Способ комплексной реабилитации больных нейродермитом |